Form 4 for INSM INSMED Inc
Accepted 2023-10-31 00:00:00 ET · period of report 2023-10-27 · accession 0001628280-23-035712 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2023-10-31 | 2023-10-27 | INSM | Lewis William | COB, CEO, Dir | M - OptEx | $14.24 | +112.5K | 500 | New | +$1.60M |
| DMI | 2023-10-31 | 2023-10-27 | INSM | Lewis William | COB, CEO, Dir | S - Sale+OE | $24.08 | -112.0K | 233.9K | -32% | -$2.70M |
| DMI | 2023-10-31 | 2023-10-27 | INSM | Lewis William | COB, CEO, Dir | M - OptEx | $0.00 | -112.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-27 | M | A | 53,363 | $14.24 | 53,363 | I Indirect | — | — | (F2) By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A11/1/2020 |
| 2 | Common | Common Stock | 2023-10-27 | S | D | 53,363 | $24.04 | 0 | I Indirect | — | — | (F3) This is the weighted average sales price representing 53,363 shares sold at prices ranging from $23.68 to $24.60 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. (F2) By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A11/1/2020 |
| 3 | Common | Common Stock | 2023-10-27 | M | A | 1,322 | $14.24 | 1,322 | I Indirect | — | — | (F2) By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A11/1/2020 |
| 4 | Common | Common Stock | 2023-10-27 | S | D | 1,322 | $25.08 | 0 | I Indirect | — | — | (F4) This is the weighted average sales price representing 1,322 shares sold at prices ranging from $24.83 to $25.40 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. (F2) By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A11/1/2020 |
| 5 | Common | Common Stock | 2023-10-27 | M | A | 315 | $14.24 | 315 | I Indirect | — | — | (F2) By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A11/1/2020 |
| 6 | Common | Common Stock | 2023-10-27 | S | D | 315 | $26.00 | 0 | I Indirect | — | — | (F2) By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A11/1/2020 |
| 7 | Common | Common Stock | 2023-10-27 | S | D | 327 | $26.00 | 233,924 | I Indirect | — | — | (F5) By ARTICLE 4 KATIE PROCTER DYNASTY TRUST |
| 8 | Common | Common Stock | 2023-10-27 | M | A | 55,350 | $14.24 | 289,274 | I Indirect | — | — | (F5) By ARTICLE 4 KATIE PROCTER DYNASTY TRUST |
| 9 | Common | Common Stock | 2023-10-27 | S | D | 55,350 | $24.04 | 233,924 | I Indirect | — | — | (F6) This is the weighted average sales price representing 55,350 shares sold at prices ranging from $23.65 to $24.63 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. (F5) By ARTICLE 4 KATIE PROCTER DYNASTY TRUST |
| 10 | Common | Common Stock | 2023-10-27 | M | A | 1,323 | $14.24 | 235,247 | I Indirect | — | — | (F5) By ARTICLE 4 KATIE PROCTER DYNASTY TRUST |
| 11 | Common | Common Stock | 2023-10-27 | S | D | 1,323 | $25.05 | 233,924 | I Indirect | — | — | (F7) This is the weighted average sales price representing 1,323 shares sold at prices ranging from $24.83 to $25.40 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. (F5) By ARTICLE 4 KATIE PROCTER DYNASTY TRUST |
| 12 | Common | Common Stock | 2023-10-27 | M | A | 327 | $14.24 | 234,251 | I Indirect | — | — | (F5) By ARTICLE 4 KATIE PROCTER DYNASTY TRUST |
| 13 | Common | Common Stock | 2023-10-27 | M | A | 500 | $14.24 | 500 | I Indirect | — | — | (F2) By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A11/1/2020 |
| 14 | Derivative | Stock Option (right to buy) | 2023-10-27 | M | D | 500 | $0.00 | 0 | I By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A 11/1/2020 | $14.24 · — to 2023-10-31 | 500 Common Stock | (F9) The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable and were scheduled to expire on October 31, 2023. |
| 15 | Derivative | Stock Option (right to buy) | 2023-10-27 | M | D | 55,000 | $0.00 | 500 | I By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A 11/1/2020 | $14.24 · — to 2023-10-31 | 55,000 Common Stock | (F9) The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable and were scheduled to expire on October 31, 2023. |
| 16 | Derivative | Stock Option (right to buy) | 2023-10-27 | M | D | 57,000 | $0.00 | 0 | I By ARTICLE 4 TRUST UNDER KATIE PROCTER DYNASTY TRUST | $14.24 · — to 2023-10-31 | 57,000 Common Stock | (F9) The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable and were scheduled to expire on October 31, 2023. |